Trial intelligence / Profile preview

Insulin Glulisine vs Aspart in Prepubertal Children with T1DM

NCT00913497Phase 4Completed

Sponsor
Corewell Health
Start
Jun 2009
Primary completion
Jan 2012
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Corewell Health. Started Jun 2009; status: completed.

02

Drugs

insulin glulisine
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00913497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00913497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call